Related Experiment Video
Updated: Sep 24, 2025
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
7.0K
Adefovir for lamivudine-resistant hepatitis B.
Rebecca Roediger1, Elizabeth Kula Smyth2, Douglas Dieterich1
1Division of Liver Disease, Department of Medicine, 5925Icahn School of Medicine, New York, NY, USA.
Antiviral Therapy
|May 2, 2022
Summary
Adefovir, a nucleotide analog, revolutionized Hepatitis B treatment by effectively suppressing viral replication and inflammation with rare resistance. This breakthrough offered a new era for managing chronic Hepatitis B infection.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic Hepatitis B treatment options were previously limited and often ineffective.
- Interferon had significant side effects and low efficacy.
- Lamivudine demonstrated short-term effects with high resistance rates.
Purpose of the Study:
- To review the landmark trials of adefovir.
- To highlight John Martin's contribution to Hepatitis B treatment.
- To discuss the impact of adefovir on managing chronic Hepatitis B.
Main Methods:
- Review of landmark clinical trials for adefovir.
- Analysis of adefovir's efficacy in suppressing Hepatitis B virus (HBV) replication.
- Evaluation of adefovir's safety and resistance profile.
Main Results:
- Adefovir demonstrated significant suppression of viral replication.
- Adefovir effectively resolved hepatic inflammation associated with Hepatitis B.
- Rare instances of adefovir resistance were observed.
Conclusions:
- Adefovir represented a major breakthrough in Hepatitis B treatment.
- Adefovir offered a new era of effective Hepatitis B management.
- John Martin's development of adefovir significantly advanced medical science.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
47.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.1K
02:33Retroviruses
12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K
01:29Subviral Agents
145
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
145